These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 3311389)

  • 1. [Methods of monitoring therapeutic agents. I. Use of homogeneous fluorescence immunoanalysis with substrate markers].
    Babjuk J; Bilyk I; Kalousová J; Nekvasilová H; Rybáková B
    Cesk Farm; 1987 Sep; 36(7):322-6. PubMed ID: 3311389
    [No Abstract]   [Full Text] [Related]  

  • 2. Automation of the homogeneous substrate-labeled fluorescent immunoassay for theophylline in serum: application to the determination of phenytoin and phenobarbital in serum.
    Fingerhut B; Costanzo R; Chaudri Z; Rizvi S
    Ther Drug Monit; 1982; 4(4):419-25. PubMed ID: 6760476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Ames Seralyzer for the therapeutic drug monitoring of phenobarbital and phenytoin.
    Brettfeld C; Gobrogge R; Massoud N; Munzenberger P; Nigro M; Sarnaik A
    Ther Drug Monit; 1989 Sep; 11(5):612-5. PubMed ID: 2683255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of a new automated substrate-labeled fluorescence immunoassay system evaluated by comparative therapeutic monitoring of five drugs.
    Klotz U
    Ther Drug Monit; 1984; 6(3):355-9. PubMed ID: 6390798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Competitive rate nephelometric immunoassay for determination of theophylline, phenobarbital, and dilantin in serum.
    Lee JH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1982 Aug; 15(3):245-9. PubMed ID: 6754287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Abbott TDx for the stat measurement of phenobarbital, phenytoin, carbamazepine, and theophylline.
    Loomis KF; Frye RM
    Am J Clin Pathol; 1983 Nov; 80(5):686-91. PubMed ID: 6637881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence polarization immunoassay. iii. an automated system for therapeutic drug determination.
    Jolley ME; Stroupe SD; Schwenzer KS; Wang CJ; Lu-Steffes M; Hill HD; Popelka SR; Holen JT; Kelso DM
    Clin Chem; 1981 Sep; 27(9):1575-9. PubMed ID: 7261335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring pediatric serum theophylline, phenobarbital, and phenytoin with the IL Multistat III.
    Iosefsohn M; Hicks JM
    Ther Drug Monit; 1980; 2(3):249-53. PubMed ID: 7013164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence polarization immunoassay IV. Determination of phenytoin and phenobarbital in human serum and plasma.
    Lu-Steffes M; Pittluck GW; Jolley ME; Panas HN; Olive DL; Wang CH; Nystrom DD; Keegan CL; Davis TP; Stroupe SD
    Clin Chem; 1982 Nov; 28(11):2278-82. PubMed ID: 6751601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emergency gas-chromatographic assay of phenobarbital and phenytoin and liquid-chromatographic assay of theophylline.
    Shihabi ZK
    Clin Chem; 1978 Sep; 24(9):1630-3. PubMed ID: 688630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Determination of theophylline, phenobarbital and valproic acid by chromatographic and immunologic technics. Comparison of methods].
    Vinçon G; Demotes-Mainard F; Bistue C; Jarry C; Brachet-Liermain A; Albin H
    Ann Biol Clin (Paris); 1984; 42(6):427-32. PubMed ID: 6442547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical evaluation of five therapeutic drugs using dry film multilayer technology on the OPUS immunoassay system.
    Jandreski MA; Shah JC; Garbincius J; Bermes EW
    J Clin Lab Anal; 1991; 5(6):415-21. PubMed ID: 1774606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous determination of phenytoin and phenobarbital in serum by spin immunoassay.
    Sayo H; Hosokawa M
    Chem Pharm Bull (Tokyo); 1984 Apr; 32(4):1675-8. PubMed ID: 6467466
    [No Abstract]   [Full Text] [Related]  

  • 14. Simultaneous determination of phenytoin and phenobarbital in serum or plasma by substrate-labeled fluorescent immunoassay.
    Dean KJ; Thompson SG; Burd JF; Buckler RT
    Clin Chem; 1983 Jun; 29(6):1051-6. PubMed ID: 6303626
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of an automated system (Optimate) for substrate-labeled fluorescent immunoassays.
    Sheehan M; Caron G
    Ther Drug Monit; 1985; 7(1):108-14. PubMed ID: 3887666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amperometric homogeneous competitive immunoassay in a perfluorocarbon emulsion oxygen therapeutic (PEOT).
    Barlag RE; Halsall HB; Heineman WR
    Anal Bioanal Chem; 2013 Apr; 405(11):3541-7. PubMed ID: 23104312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homogeneous substrate-labeled fluorescent immunoassay for theophylline in serum.
    Li TM; Benovic JL; Buckler RT; Burd JF
    Clin Chem; 1981 Jan; 27(1):22-6. PubMed ID: 7449119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparison of i-PiT, TDX and EMIT measurement of serum phenytoin and digoxin levels].
    Koizumi F; Kumai M; Ishimori A
    Rinsho Byori; 1985 Jul; 33(7):761-70. PubMed ID: 3906186
    [No Abstract]   [Full Text] [Related]  

  • 19. [Quantitative determination of phenobarbital in human blood serum by fluorescence polarization immunoanalysis].
    Dzgoev AB; Eremin SA; Danilova NP; Egorov AM; Vasilov RG
    Vopr Med Khim; 1991; 37(3):85-6. PubMed ID: 1949701
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative determination of phenytoin in plasma by fluorescence polarization immunoassay and high performance liquid chromatography.
    Othman S; al-Turk WA; Awidi AS; Daradkeh TK; Shaheen O
    Drug Des Deliv; 1987 Sep; 2(1):41-7. PubMed ID: 3334544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.